Healthcare remains a key issue for voters ahead of the 2020 elections, with drug pricing reform, patient affordability and the changing role of the consumer as major themes for both the U.S. pharmaceutical industry and the 2020 presidential candidates. J.P. Morgan Research explores the outlook for the industry in 2020 ahead of the election and beyond. This podcast was recorded on December 5, 2019.This communication is provided for information purposes only. Please read the related report at https://www.jpmorgan.com/global/research/health-care-2020-election for more information including important disclosures. © 2019 JPMorgan Chase & Co. All rights reserved.